Ownership history in US BANCORP \DE\ · 14 quarters on record
This page tracks every 13F SEC filing in which US BANCORP \DE\ reported a position in SONOMA PHARMACEUTICALS INC (SNOA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 25 | — | 0% | 0.00% | $91 | $3.64 |
| 2025 Q3 | UNCHANGED | 25 | — | 0% | 0.00% | $97 | $3.88 |
| 2025 Q2 | UNCHANGED | 25 | — | 0% | 0.00% | $71 | $2.85 |
| 2025 Q1 | UNCHANGED | 25 | — | 0% | 0.00% | $55 | $2.19 |
| 2024 Q4 | UNCHANGED | 25 | — | 0% | 0.00% | $67 | $2.69 |
| 2024 Q3 | UNCHANGED | 25 | — | 0% | 0.00% | $77 | $3.07 |
| 2000 Q4 | UNCHANGED | 25 | — | 0% | 0.00% | $91 | — |
| 2000 Q3 | UNCHANGED | 25 | — | 0% | 0.00% | $91 | — |
| 2000 Q2 | UNCHANGED | 25 | — | 0% | 0.00% | $91 | — |
| 2000 Q1 | UNCHANGED | 25 | — | 0% | 0.00% | $91 | — |
As of 2025 Q4 — sorted by position size